Patient outcomes in liver transplantation for hepatocellular carcinoma at a major transplant center in the United States

被引:0
作者
Schafer, Michael
Schafer, Daniel F.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A804 / A804
页数:1
相关论文
共 50 条
  • [21] The closing survival gap after liver transplantation for hepatocellular carcinoma in the United States
    Liu, Hao
    Kaltenmeier, Christof
    Jonassaint, Naudia
    Behari, Jaideep
    -Rojo, Andres Duarte
    Malik, Shahid
    Hughes, Dempsey L.
    Ganesh, Swaytha
    Reddy, Dheera
    Powers, Colin
    Loseth, Caitlin
    Thompson, Ann
    Al Harakeh, Hasan
    Hill, Roy
    Xingyu, Zhang
    Diego, Emilia
    Di Martini, Andrea
    Bataller, Ramon
    Molinari, Michele
    HPB, 2022, 24 (11) : 1994 - 2005
  • [22] Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
    Inkyu S Lee
    Kenji Okumura
    Ryosuke Misawa
    Hiroshi Sogawa
    Gregory Veillette
    Devon John
    Thomas Diflo
    Seigo Nishida
    Abhay Dhand
    World Journal of Hepatology, 2023, (04) : 554 - 563
  • [23] Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
    Lee, Inkyu S.
    Okumura, Kenji
    Misawa, Ryosuke
    Sogawa, Hiroshi
    Veillette, Gregory
    John, Devon
    Diflo, Thomas
    Nishida, Seigo
    Dhand, Abhay
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) : 554 - 563
  • [24] Patterns and Outcomes Associated with Patient Migration for Liver Transplantation in the United States
    Croome, Kristopher P.
    Lee, David D.
    Burns, Justin M.
    Perry, Dana K.
    Keaveny, Andrew P.
    Taner, C. Burcin
    PLOS ONE, 2015, 10 (10):
  • [25] Racial Disparities in Liver Transplant Outcomes Are Consistent Regardless of Transplant Center Characteristics in the United States
    Ross, K.
    Lynch, R.
    Patzer, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 265 - 265
  • [26] Factors Associated with Hepatocellular Carcinoma Understaging for Liver Transplantation, and Variation in Understaging by Transplant Center
    Mahmud, N.
    Hoteit, M.
    Goldberg, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 489 - 490
  • [27] Outcomes of Screening for Hepatocellular Carcinoma in the United States
    Davila, Jessica A.
    Richardson, Peter
    Morgan, Robert O.
    Du, Xianglin L.
    McGlynn, Katherine A.
    El-Serag, Hashem B.
    GASTROENTEROLOGY, 2009, 136 (05) : A804 - A804
  • [28] Outcomes in liver transplantation for hepatocellular carcinoma versus incidental hepatocellular carcinoma
    Wancata, L.
    Olyaei, A.
    McKenna, D.
    Busch, A.
    Burg, J.
    Chang, M.
    Orloff, S.
    TRANSPLANTATION, 2022, 106 (8S) : 115 - 115
  • [29] Long-Term Outcomes of Living Donor Versus Deceased Donor Liver Transplant for Hepatocellular Carcinoma in the United States
    Muhammad, Haris
    Gurakar, Merve
    Ting, Peng-Sheng
    Alsughayer, Anas M.
    Luu, Harry
    Zaffar, Duha
    Alqahtani, Saleh
    Bonder, Alan
    Gurakar, Ahmet
    Saberi, Behnam
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (03) : 279 - 284
  • [30] Down-staging of hepatocellular carcinoma tumors at liver transplant centers in the United States
    Wong, She-Yan
    Halegoua-De Marzio, Dina
    Civan, Jesse M.
    HEPATOLOGY, 2014, 60 : 888A - 889A